NO20080358L - Fremgangsmater og sammensetninger for a fremstille negative-sense virus RNA i hundedyrceller - Google Patents
Fremgangsmater og sammensetninger for a fremstille negative-sense virus RNA i hundedyrcellerInfo
- Publication number
- NO20080358L NO20080358L NO20080358A NO20080358A NO20080358L NO 20080358 L NO20080358 L NO 20080358L NO 20080358 A NO20080358 A NO 20080358A NO 20080358 A NO20080358 A NO 20080358A NO 20080358 L NO20080358 L NO 20080358L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- compositions
- virus rna
- producing negative
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69296505P | 2005-06-21 | 2005-06-21 | |
US69297805P | 2005-06-21 | 2005-06-21 | |
US69955505P | 2005-07-15 | 2005-07-15 | |
US69955605P | 2005-07-15 | 2005-07-15 | |
US70200605P | 2005-07-22 | 2005-07-22 | |
US79352506P | 2006-04-19 | 2006-04-19 | |
US79352206P | 2006-04-19 | 2006-04-19 | |
PCT/US2006/023867 WO2007002008A2 (fr) | 2005-06-21 | 2006-06-20 | Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080358L true NO20080358L (no) | 2008-03-03 |
Family
ID=37595721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080358A NO20080358L (no) | 2005-06-21 | 2008-01-18 | Fremgangsmater og sammensetninger for a fremstille negative-sense virus RNA i hundedyrceller |
Country Status (11)
Country | Link |
---|---|
US (4) | US20060286591A1 (fr) |
EP (2) | EP1917361A4 (fr) |
JP (2) | JP2008543331A (fr) |
KR (2) | KR20080024212A (fr) |
AU (2) | AU2006262381A1 (fr) |
BR (1) | BRPI0612268A2 (fr) |
CA (2) | CA2613283A1 (fr) |
IL (1) | IL188202A0 (fr) |
NO (1) | NO20080358L (fr) |
RU (1) | RU2008101367A (fr) |
WO (2) | WO2007002007A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7959929B2 (en) | 2005-04-21 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7790434B2 (en) | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
EP1917361A4 (fr) | 2005-06-21 | 2009-07-29 | Medimmune Vaccines Inc | Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
AU2007240448B8 (en) * | 2006-04-19 | 2014-03-06 | Medimmune Llc. | Methods and compositions for expressing negative-sense viral RNA in canine cells |
ES2694805T7 (es) | 2006-09-11 | 2021-10-21 | Seqirus Uk Ltd | Fabricación de vacunas contra virus de la gripe sin usar huevos |
US9163053B2 (en) * | 2007-05-18 | 2015-10-20 | Fluidigm Corporation | Nucleotide analogs |
MY152175A (en) | 2007-06-26 | 2014-08-15 | Japan Health Science Found | Vaccine antigen capable of inducing cross-reacting and neutralizing antibody againts high-risk-type human papillomavirus |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
JP5548207B2 (ja) | 2008-09-24 | 2014-07-16 | メディミューン,エルエルシー | ウイルスの精製方法 |
USH2284H1 (en) | 2009-04-27 | 2013-09-03 | Novartis Ag | Vaccines for protecting against influenza |
KR101800245B1 (ko) * | 2009-05-21 | 2017-11-22 | 노파르티스 아게 | 비-내인성 pol i 프로모터를 사용하는 역 유전학 |
WO2011012999A1 (fr) | 2009-07-31 | 2011-02-03 | Novartis Ag | Systemes de genetique inverse |
CN102220437B (zh) * | 2011-04-27 | 2014-04-23 | 贵州省烟草科学研究所 | 部分接种鉴定烟草病毒病抗性的方法 |
JP6054883B2 (ja) | 2012-03-02 | 2016-12-27 | ノバルティス アーゲー | インフルエンザウイルスの再集合 |
GB201220119D0 (en) * | 2012-11-08 | 2012-12-26 | Univ Cork | Vector |
AU2013354219A1 (en) | 2012-12-03 | 2015-07-02 | Novartis Ag | Reassortant influenza a viren |
AU2014229255B2 (en) | 2013-03-13 | 2018-12-13 | Novartis Ag | Influenza B virus reassortment |
DE202013005100U1 (de) | 2013-06-05 | 2013-08-26 | Novartis Ag | Influenza Virus Reassortierung |
DE202013005130U1 (de) | 2013-06-05 | 2013-09-10 | Novartis Ag | Influenza Virus Reassortierung |
CA2914604A1 (fr) | 2013-06-06 | 2014-12-11 | Novartis Ag | Reassortiment du virus de la grippe |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
WO2016148195A1 (fr) * | 2015-03-17 | 2016-09-22 | 一般財団法人阪大微生物病研究会 | Cellules pour la production de virus de la grippe |
CN106520700B (zh) * | 2016-11-10 | 2019-12-27 | 中国食品药品检定研究院 | 稳定表达牛胰蛋白酶原的mdck细胞系及其用途 |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
JPWO2020004425A1 (ja) * | 2018-06-27 | 2021-07-08 | 一般財団法人阪大微生物病研究会 | インフルエンザウイルスの培養方法 |
CN109762938B (zh) * | 2019-02-01 | 2022-06-10 | 中国水产科学研究院珠江水产研究所 | 用于区分鳜鱼弹状病毒vRNA、cRNA和mRNA的引物组合及试剂盒 |
CN109652384B (zh) * | 2019-02-21 | 2021-10-26 | 昆明理工大学 | 一种体外培养戊型肝炎病毒的方法 |
BR102020010208A2 (pt) | 2020-05-21 | 2022-04-12 | Fundação Oswaldo Cruz | Construção de ácido nucleico, virus influenza recombinante, método para preparar um virus influenza recombinante, composição, e, uso. |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001634A (en) * | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
US6887699B1 (en) * | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
US6348327B1 (en) * | 1991-12-06 | 2002-02-19 | Genentech, Inc. | Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
EP1394259A3 (fr) | 1994-07-18 | 2004-04-14 | Karl-Klaus Prof. Dr. Conzelmann | Virus ARM récombinant, infectieux, non-segmenté, brin-negatif |
FR2723104B1 (fr) * | 1994-07-27 | 1996-09-13 | Rhone Poulenc Rorer Sa | Nouvelle topoisomerase iv, sequences nucleotiques correspondantes et leurs utilisations |
US5824536A (en) * | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
US5789229A (en) * | 1994-09-30 | 1998-08-04 | Uab Research Foundation | Stranded RNA virus particles |
US5753489A (en) * | 1994-11-10 | 1998-05-19 | Immuno Ag | Method for producing viruses and vaccines in serum-free culture |
AU694592B2 (en) | 1994-11-16 | 1998-07-23 | St. Jude Children's Research Hospital | Novel replication process |
US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
US5690937A (en) * | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
DE69510207T3 (de) | 1995-08-09 | 2007-02-15 | Schweiz. Serum- & Impfinstitut Bern | Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren |
WO1997012032A1 (fr) | 1995-09-27 | 1997-04-03 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Production de virus syncytial respiratoire infectieux a partir de sequences de nucleotides clones |
KR100894670B1 (ko) | 1996-07-15 | 2009-04-22 | 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 | 클론닝된 뉴클레오타이드 서열로부터 약독화된 호흡기 세포융합 바이러스 백신의 생산 |
CN1232504A (zh) | 1996-09-27 | 1999-10-20 | 美国氰胺公司 | 在单链负义病毒目病毒内引起减毒的3'基因组启动子区和聚合酶基因中的突变 |
KR100702523B1 (ko) | 1997-05-23 | 2007-04-04 | 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 | 클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법 |
PT1012244E (pt) | 1997-07-11 | 2007-08-21 | Univ Yale | ''rabdovírus com revestimentos remanipulados'' |
US6946291B2 (en) * | 1998-04-24 | 2005-09-20 | University Hospitals Of Cleveland | Mixed cell diagnostic systems |
US6544785B1 (en) * | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
US6146642A (en) * | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
DK1194580T4 (da) | 1999-07-14 | 2011-01-03 | Sinai School Medicine | In-vitro rekonstitution af segmenterede negativstrengede RNA-virus |
US6951754B2 (en) | 2000-04-28 | 2005-10-04 | St. Jude Children's Research Hospital | DNA transfection system for the generation of infectious influenza virus |
WO2002006453A2 (fr) * | 2000-07-18 | 2002-01-24 | Bayer Aktiengesellschaft | Regulation de protease a serine humaine de type desc1 |
US20040241139A1 (en) * | 2000-07-20 | 2004-12-02 | Gerd Hobom | Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
ES2563402T3 (es) * | 2002-02-13 | 2016-03-15 | Wisconsin Alumni Research Foundation | Señal para el empaquetamiento de vectores del virus de la gripe |
WO2003072725A2 (fr) * | 2002-02-21 | 2003-09-04 | Mount Sinai School Of Medicine | Systemes et vaccins d'expression d'arn a brin negatif recombinant |
US7465456B2 (en) * | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
WO2003091401A2 (fr) | 2002-04-26 | 2003-11-06 | Medimmune Vaccines, Inc. | Systeme multiplasmide de production de virus influenza |
US7132523B2 (en) * | 2002-07-03 | 2006-11-07 | Ortho-Mcneil Pharmaceutical, Inc. | Human PRSS11-Like S2 serine protease and uses thereof |
AU2003287105A1 (en) * | 2002-10-10 | 2004-05-04 | Verenium Corporation | Proteases, nucleic acids encoding them and methods for making and using them |
JP4617300B2 (ja) * | 2003-02-25 | 2011-01-19 | メディミューン,エルエルシー | インフルエンザワクチン組成物を生成する方法 |
CA2421086A1 (fr) * | 2003-02-28 | 2004-08-28 | Institut Pasteur | Promoteur de l'arn polymerase i de poulet et son utilisation |
WO2004112831A2 (fr) * | 2003-05-28 | 2004-12-29 | Wisconsin Alumni Research Foundation | Virus influenza de recombinaison a titre eleve pour vaccins et therapie genique |
CA2526834A1 (fr) * | 2003-05-28 | 2005-03-31 | Wisconsin Alumni Research Foundation | Vecteurs de la grippe recombines contenant un promoteur pol ii et des ribozymes |
JP4771959B2 (ja) * | 2003-12-23 | 2011-09-14 | メディミューン,エルエルシー | インフルエンザウイルス作製のための多重プラスミド系 |
JP5620048B2 (ja) * | 2004-12-24 | 2014-11-05 | アボツト・バイオロジカルズ・ベー・ブイAbbott Biologicals B.V. | インフルエンザウイルスの救済(rescue) |
EP1917361A4 (fr) | 2005-06-21 | 2009-07-29 | Medimmune Vaccines Inc | Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines |
US7790434B2 (en) * | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
AU2007240448B8 (en) * | 2006-04-19 | 2014-03-06 | Medimmune Llc. | Methods and compositions for expressing negative-sense viral RNA in canine cells |
-
2006
- 2006-06-20 EP EP06773570A patent/EP1917361A4/fr not_active Withdrawn
- 2006-06-20 CA CA002613283A patent/CA2613283A1/fr not_active Abandoned
- 2006-06-20 RU RU2008101367/13A patent/RU2008101367A/ru not_active Application Discontinuation
- 2006-06-20 JP JP2008518287A patent/JP2008543331A/ja active Pending
- 2006-06-20 AU AU2006262381A patent/AU2006262381A1/en not_active Abandoned
- 2006-06-20 WO PCT/US2006/023866 patent/WO2007002007A2/fr active Application Filing
- 2006-06-20 KR KR1020087001609A patent/KR20080024212A/ko not_active Application Discontinuation
- 2006-06-20 US US11/455,734 patent/US20060286591A1/en not_active Abandoned
- 2006-06-20 KR KR1020087001669A patent/KR20080025171A/ko not_active Application Discontinuation
- 2006-06-20 AU AU2006262380A patent/AU2006262380A1/en not_active Abandoned
- 2006-06-20 WO PCT/US2006/023867 patent/WO2007002008A2/fr active Application Filing
- 2006-06-20 BR BRPI0612268-0A patent/BRPI0612268A2/pt not_active IP Right Cessation
- 2006-06-20 CA CA002613284A patent/CA2613284A1/fr not_active Abandoned
- 2006-06-20 JP JP2008518286A patent/JP2008546408A/ja active Pending
- 2006-06-20 EP EP06773569A patent/EP1917352A4/fr not_active Withdrawn
-
2007
- 2007-12-17 IL IL188202A patent/IL188202A0/en unknown
-
2008
- 2008-01-18 NO NO20080358A patent/NO20080358L/no not_active Application Discontinuation
-
2010
- 2010-02-17 US US12/706,994 patent/US20100203641A1/en not_active Abandoned
- 2010-07-23 US US12/842,854 patent/US8278433B2/en not_active Expired - Fee Related
-
2012
- 2012-08-31 US US13/601,401 patent/US8742089B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100203641A1 (en) | 2010-08-12 |
US8278433B2 (en) | 2012-10-02 |
WO2007002007A3 (fr) | 2007-06-21 |
EP1917361A4 (fr) | 2009-07-29 |
US8742089B2 (en) | 2014-06-03 |
US20110045586A1 (en) | 2011-02-24 |
WO2007002007A2 (fr) | 2007-01-04 |
AU2006262381A1 (en) | 2007-01-04 |
CA2613284A1 (fr) | 2007-01-04 |
JP2008546408A (ja) | 2008-12-25 |
RU2008101367A (ru) | 2009-08-10 |
KR20080024212A (ko) | 2008-03-17 |
KR20080025171A (ko) | 2008-03-19 |
EP1917352A4 (fr) | 2009-03-25 |
EP1917361A2 (fr) | 2008-05-07 |
WO2007002007A8 (fr) | 2007-05-10 |
WO2007002008A2 (fr) | 2007-01-04 |
WO2007002008A3 (fr) | 2007-12-27 |
JP2008543331A (ja) | 2008-12-04 |
EP1917352A2 (fr) | 2008-05-07 |
IL188202A0 (en) | 2008-03-20 |
CA2613283A1 (fr) | 2007-01-04 |
AU2006262380A1 (en) | 2007-01-04 |
US20060286591A1 (en) | 2006-12-21 |
BRPI0612268A2 (pt) | 2009-01-27 |
US20120329150A1 (en) | 2012-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080358L (no) | Fremgangsmater og sammensetninger for a fremstille negative-sense virus RNA i hundedyrceller | |
AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
WO2021159040A3 (fr) | Vaccins à domaine arnm anti sars-cov-2 | |
BRPI0516221A (pt) | método de produção de vìrus de uma cultura de células, composição, e, método de produção de reovìrus infeccioso | |
EA201000195A1 (ru) | Вирусоподобные частицы вируса гриппа, включающие гемагглютинин, продуцированный в растении | |
ATE539736T1 (de) | Virosome mit hämagglutinin aus einem influenza- virus, der in einer zelllinie produziert wurde, zusammensetzungen, herstellungsverfahren und anwendungen davon | |
BR0309659A (pt) | Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso | |
EP3199545A3 (fr) | Antigènes réactifs à large spectre optimisés par le calcul pour le virus de la grippe h1n1 | |
ATE543873T1 (de) | Herstellung von 3-hydroxypropionsäure mittels beta-alanine-pyruvat-aminotrransferase | |
JP2010207233A5 (fr) | ||
WO2010003225A8 (fr) | Particules de type virus (vlp) de la grippe comprenant de l'hémagglutinine | |
CY1114736T1 (el) | Προερχομενες απο παπια εμβρυϊκες βλαστικες κυτταρικες σειρες για την παραγωγη ιικων εμβολιων | |
EA201291024A1 (ru) | Композиции эндорибонуклеаз и способы их использования | |
WO2005042728A3 (fr) | Lignees de cellules aviaires immortalisees pour la production de virus | |
WO2006063053A3 (fr) | Methodes de preparation de vaccins contre la grippe | |
DK1929001T3 (da) | Nye dehydrogenaser, disses derivater og en fremgangsmåde til fremstilling af optisk aktive alkanoler | |
WO2005115448A3 (fr) | Systeme multiplasmide pour la production d'un virus grippal | |
WO2012014207A3 (fr) | Procédé de génération de cellules souches pluripotentes induites à partir de kératinocytes dérivés de follicules pileux prélevés | |
MY166220A (en) | Rabies virus like particle production in plants | |
WO2009099877A3 (fr) | Vecteurs de closterovirus et procédés | |
MX358883B (es) | Aumentar el rendimiento de particulas similares a virus en plantas. | |
AR079710A1 (es) | Proceso para el cultivo de celulas adherentes | |
BR112013014082A2 (pt) | "moléculas de rna, micro-rna e de ácido nucleico, composições e construtos compreendendo as mesmas, bem como métodos para melhorar a resistência 5 de uma planta à infecção, controlar a infecção e reduzir o desenvolvimento do cisto de um nematódeo, para produção de uma célula ou de uma planta possuindo resistência a nematódeo e para melhorar a produtividade". | |
EA201690232A1 (ru) | Генетически стабильный онколитический рнк вирус, способ его производства и применения | |
PH12020552252A1 (en) | Influenza virus hemagglutinin mutants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |